Based on decades of research
Panaxium’s neural interface is as thin as the diameter of a red blood cell
Gently conforming to the brain’s surface
- Provides unprecedented resolution and activation control for stimulating into the critical Cortical Layer 5.
- Ability to record activity to adjust therapy & predict movement intent.
- Option for combination therapies with neuron-scale precision drug delivery (neurotransmitters, regenerative pre-cursors) within the same device layer.
We’re tackling a huge problem first: stroke
- 1 in 4 people will suffer a stroke during their lifetime
- 9 of 10 survivors are left with life-altering cognitive, motor, and speech disabilities following the current recovery programs
- $700 Billion societal cost every year
Panaxium’s preclinical studies are currently underway at world-leading sites in Europe and North America.
AI-enabled neuro-imaging
- Panaxium’s proprietary MRI protocol & AI-assisted analysis generates complete patient-specific representations of entire functional networks.
- Identifies specific disruption from damage, predicts natural recovery, and aids planning for the implantation.